Kiniksa Pharmaceuticals International Plc (KNSA)
48.43
+0.05
(+0.10%)
USD |
NASDAQ |
Jun 01, 16:00
48.46
+0.03
(+0.06%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International EPS Diluted (Quarterly) : 0.2741 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -0.2686 |
| Barinthus Biotherapeutics Plc | -0.1352 |
| Scancell Holdings Plc | -- |
| OptiBiotix Health Plc | -- |
| Aurinia Pharmaceuticals, Inc. | 0.2496 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 22.59M |
| Revenue (Quarterly) | 214.27M |
| Total Expenses (Quarterly) | 191.67M |
| Enterprise Value | 3.267B |
| Gross Profit Margin (Quarterly) | 54.95% |
| Profit Margin (Quarterly) | 10.54% |
| Earnings Yield | 1.87% |
| Operating Earnings Yield | 2.39% |
| Normalized Earnings Yield | 1.873 |